1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide methiodide has been researched along with 1,5-difluoro-2,4-dinitrobenzene in 1 studies
| Studies (1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide methiodide) | Trials (1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide methiodide) | Recent Studies (post-2010) (1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide methiodide) | Studies (1,5-difluoro-2,4-dinitrobenzene) | Trials (1,5-difluoro-2,4-dinitrobenzene) | Recent Studies (post-2010) (1,5-difluoro-2,4-dinitrobenzene) |
|---|---|---|---|---|---|
| 52 | 0 | 2 | 55 | 0 | 6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aubonney, N; Beavil, RL; Bonnefoy, JY; Gould, HJ; Graber, P | 1 |
1 other study(ies) available for 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide methiodide and 1,5-difluoro-2,4-dinitrobenzene
| Article | Year |
|---|---|
CD23/Fc epsilon RII and its soluble fragments can form oligomers on the cell surface and in solution.
Topics: B-Lymphocytes; Cell Line; Dinitrofluorobenzene; Ethyldimethylaminopropyl Carbodiimide; Humans; Immunoglobulin Fragments; Molecular Weight; Receptors, IgE | 1995 |